Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet-derived growth factor receptors (PDGFRs) are cell surface receptor tyrosine kinases that play a central role in regulating cell proliferation, differentiation, growth, and development. They are especially important in connective tissue cells such as fibroblasts and smooth muscle cells. There are two main types: PDGFRα and PDGFRβ. Ligand binding induces receptor dimerization and autophosphorylation, triggering downstream signaling cascades involved in cell proliferation, migration, survival, and differentiation. Aberrant activation or overexpression/mutation of PDGFRs has been implicated in various diseases including cancers, fibrotic disorders, and atherosclerosis, making them important therapeutic targets.
Tyrosine kinase inhibition (for targeted therapies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet-Derived Growth Factor Receptor (PDGFR).